Fadia T. Shaya, Ph.D., M.P.H.
Assistant Professor
Center on Drugs and Public Policy
University of Maryland School of Pharmacy

Fadia Shaya obtained her PhD from the Johns Hopkins Bloomberg School of Public Health, her masters from the Sorbonne University Paris-IX, and completed a post-doctoral fellowship in pharmacoeconomics and formulary management at the University of Maryland School of Pharmacy and CareFirst Blue Cross Blue Shield. 

Dr. Shaya is Associate Director for the Center on Drugs and Public Policy in the Department of Pharmaceutical Health Services Research.  Dr. Shaya has experience in developing clinical, economic, decision analysis and budget impact models.  Her expertise is in formulary management and managed care issues.  Dr. Shaya is a member of the P&T committee at Care First Blue Cross Blue Shield, and a member of the Editorial Advisory Boards for the Journal of Managed Care Pharmacy and Expert Review in Pharmacoeconomics and Outcomes Research. She serves as a reviewer for and has published over 30 papers in a number of peer-reviewed journals, including The Lancet, Health Affairs and Archives of Internal Medicine. Her current research focuses on survival analysis, propensity scores modeling and applications to formulary decision-making. Her major areas of research are respiratory and cardiovascular diseases. She has experience analyzing and handling large claims data sets, and designing retrospective as well as prospective studies.  Dr. Shaya is the recipient (Co-PI) of a $6 million grant from NHLBI, to develop and implement a partnership program to reduce cardiovascular disparities in Baltimore.
For two consecutive years, she received the Drug Information doctoral award from the US Pharmacopeia.  Prior to that, she worked in research on health care financing issues at the Health Planning Commission in Paris, France.

Currently Dr. Shaya is working with commercial and Medicaid managed care organizations formulary committees, to apply pharmacoeconomic tools to information presented for coverage decisions. She also serves as the Chair of the Governor’s Advisory Council on Hepatitis C and Diseases of the Liver, for the State of Maryland.